Isosilybin

• Description :

  Isosilybin and Silybin might be suitable candidates to design potent PXR antagonists to prevent drug-drug interactions via CYP3A4 in cancer patients.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  482.44

• Molecular Formula :

  C25H22O10

• Notes :

  Research use only, not for human use.

• Receptor :

  CYP3A4

• CAS Number :

  72581-71-6